Last Updated:
Completed
Create account to add to watchlist!
Create account to add to watchlist!

Cerevel Therapeutics Holdings, Inc. - CERE

  • Commons

    $29.83

    -1.03%

    CERE Vol: 605.7K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 4.3G
Average Volume: 672.5K
52W Range: $19.86 - $46.16
Weekly %: +8.35%
Monthly %: -1.62%
Inst Owners: 174

Info

Description: Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Industry: Biotechnology

Website: https://www.cerevel.com

🎯Price Targets

Rating

Analyst Firm

Price Target

JP Morgan

1/05/22

Overweight - $50.0

Buy - $50.0

Neutral - $27.0

Neutral - $20.0

Mizuho

08/23/22

nan - $32.0

📰News and PRs

🕵Stocktwit Mentions

oliveinvest posted at 2022-10-05T15:46:56Z

Easily find strategies like this to invest in a down or sideways market. A fixed return outcome on $CERE Make a fixed 33.4% (25.0% annualized) CERE can fall 45% thru exp before you start to lose. Buy 8 $15 puts Sell 9 $17.5 puts Exp 1/19/24 Capital Req. $2811.22 👉🏼Click my profile link to see how its done.

oliveinvest posted at 2022-10-04T17:21:23Z

Easily find strategies like this to invest in a down or sideways market. A fixed return outcome on $CERE Make a fixed 36.3% (27.0% annualized) CERE can fall 32% thru exp before you start to lose. Buy 2 $12.5 puts Buy 1 $15 put Sell 1 $17.5 put Sell 4 $25 puts Exp 1/19/24 Capital Req. $5685.28 👉🏼Click my profile link to see how its done.

InsiderFinance posted at 2022-10-03T10:44:09Z

Momentum Activity Weekly Recap: $CERE is the #4 ticker with momentum activity traded by institutions this week with options transaction volume 76.8x the average daily volume, a leading indicator of market movement. Market analysis and options contracts included in screenshot of dashboard from 🔥 INSIDERFINANCE.IO 🔥 (Link in profile - @InsiderFinance)

oliveinvest posted at 2022-10-03T07:01:10Z

Generate income with protection from volatility🛡️. Call it cushion💸. Set your cushion to whatever percentage you like. See the cushion on this fixed return outcome on $CERE Make a fixed 14.2% (23.4% annualized) CERE can fall 38% thru exp before you start to lose. Sell 2 $20 puts Exp 5/19/23 Capital Req. $3501.32 👉🏼Click my profile link to see how its done.

EarningsInsider posted at 2022-10-03T05:30:46Z

Cantor Fitzgerald Sets Cerevel Therapeutics FY2022 Earnings Estimates at ($2.35) EPS. https://www.marketbeat.com/x/1286178 $CERE

InsiderFinance posted at 2022-10-02T20:05:35Z

Momentum Activity Weekly Recap: $CERE is the #4 ticker with momentum activity traded by institutions this week with options transaction volume 76.8x the average daily volume, a leading indicator of market movement. Market analysis and options contracts included in screenshot of dashboard from 🔥 INSIDERFINANCE.IO 🔥 (Link in profile - @InsiderFinance)

InsiderFinance posted at 2022-10-01T20:05:05Z

Momentum Activity Weekly Recap: $CERE is the #4 ticker with momentum activity traded by institutions this week with options transaction volume 76.8x the average daily volume, a leading indicator of market movement. Market analysis and options contracts included in screenshot of dashboard from 🔥 INSIDERFINANCE.IO 🔥 (Link in profile - @InsiderFinance)

oliveinvest posted at 2022-10-01T17:10:48Z

Have you considered this Options strategy to beat any market? This is a fixed return outcome on $CERE Make a fixed 43.2% (31.7% annualized) CERE can fall 29% thru exp before you start to lose. Buy 3 $15 puts Sell 5 $25 puts Exp 1/19/24 Capital Req. $5585.28 👉🏼Click my profile link to see how its done.

tickeron posted at 2022-09-30T19:06:25Z

Bulls or bears - who will win? $CERE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://srnk.us/go/4031503

oliveinvest posted at 2022-09-30T16:56:56Z

A solution to the question - "How can I invest in this ticker and know what to expect?" Option #1 (of many using Olive): a fixed return strategy for $CERE Make a fixed 13.1% (37.5% annualized) CERE can fall 34% thru exp before you start to lose. Buy 1 $12.5 put Sell 2 $20 puts Exp 2/17/23 Capital Req. $2431.98 👉🏼Click my profile link to see how its done.

quantcha posted at 2022-09-30T16:42:18Z

Covered Call Alert: CEREVEL THERAPEUTICS HOLDINGS INC $CERE returning up to 35.71% through 20-Jan- https://wp.me/p5bLGB-hYH1

oliveinvest posted at 2022-09-29T19:23:16Z

Now you can invest with control from your iPhone (Olive Invest in App Store) using strats like this fixed return outcome on $CERE Make a fixed 12.9% (36.6% annualized) CERE can fall 31% thru exp before you start to lose. Buy 1 $12.5 put Sell 1 $20 put Sell 1 $22.5 put Exp 2/17/23 Capital Req. $2656.98 👉🏼Click my profile link to see how its done.

stocktargetadvisors posted at 2022-09-29T15:40:02Z

$CERE latest rating from Cantor Fitzgerald Securities on 2022-09-29, setting target price at: USD 41.00 with a rating of Overweight. StockTargetAdvisor's own view is Bearish with an average target price of USD 34.23. Details: https://www.stocktargetadvisor.com/stock/USA/NSD/CERE

spachero1 posted at 2022-09-29T15:17:48Z

📰 $CERE Analyst Ratings for Cerevel Therapeutics Hldg https://t.co/iylyDOVNdQ https://t.co/2IWqWWOZUv 2022-09-29 13:21:47https://twitter

spachero1 posted at 2022-09-29T13:17:20Z

🎯 09/29/2022 Price Targets 🟠 $BKKT - Wells Fargo & Company - $2.50 🟢 $CERE - Cantor Fitzgerald - $41.00 🟠 $GETY - The Goldman Sachs Gr

MarketBeat posted at 2022-09-29T11:31:01Z

Cerevel Therapeutics initiated by Cantor Fitzgerald at overweight. https://www.marketbeat.com/r/1823228 $CERE

Quantisnow posted at 2022-09-29T11:26:20Z

$CERE 📋 Cantor Fitzgerald initiated coverage on Cerevel Therapeutics with a new price target https://quantisnow.com/i/3469564?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-09-29T10:44:57Z

$CERE Cantor Fitzgerald analyst Charles Duncan initiates coverage on Cerevel Therapeutics Hldg with a Overweight rating and announces Price Target of $41.

oliveinvest posted at 2022-09-28T20:16:55Z

It's time you learned about Defined Outcome investing 💸 Starting with this fixed return strategy for $CERE Make a fixed 6.6% (22.6% annualized) CERE can fall 32% thru exp before you start to lose. Sell 1 $20 put Exp 1/20/23 Capital Req. $1875.66 👉🏼Click my profile link to see how its done.

oliveinvest posted at 2022-09-27T18:06:59Z

Forget "Buy and Pray🙏". Join me in using Olive's search engine to find investment strategies like this fixed return strategy for $CERE Make a fixed 4.7% (15.7% annualized) CERE can fall 38% thru exp before you start to lose. Sell 2 $17.5 puts Exp 1/20/23 Capital Req. $3341.32 👉🏼Click my profile link to see how its done.

noboytoy posted at 2022-09-26T23:47:10Z

$CERE hey idiot posters - stop posting the same spam - get a real life out of ur diapers

AmberMakesMoney posted at 2022-09-26T18:00:18Z

$cere Wells Fargo Initiates Coverage On Cerevel Therapeutics Hldg with Overweight Rating, Announces Price Target of $38

AmberMakesMoney posted at 2022-09-26T17:34:55Z

$cere Cerevel Therapeutics shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and $38 price target.

RockyTSTH posted at 2022-09-26T14:50:07Z

$CERE Cerevel Therapeutics shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and $38 price target.

stocktargetadvisors posted at 2022-09-26T14:13:01Z

$CERE latest rating from Wells Fargo on 2022-09-26, setting target price at: USD 38.00 with a rating of Overweight. StockTargetAdvisor's own view is Bearish with an average target price of USD N/A. Details: https://www.stocktargetadvisor.com/stock/USA/NSD/CERE

EPSMomentum posted at 2022-09-26T13:19:56Z

$CERE $26.21 PEADrift price projection for the next 44 days. Max $48.33 Mean $32.38 and Min $22.53 . https://epsmomentum.com/boxes?ticker=CERE&widget=pead.

Quantumup posted at 2022-09-26T12:45:43Z

Wells Fargo initiated $CERE OW/$38~most of the focus is on emraclidine in schizophrenia, due to $KRTX recent success, thinks Cerevel is a fast follower, with potential for a safer and more convenient dosing, which could help it generate $2B+ in this $7B+ opportunity.

Quantisnow posted at 2022-09-26T11:55:17Z

$CERE 📋 Wells Fargo initiated coverage on Cerevel Therapeutics with a new price target https://quantisnow.com/i/3450875?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-09-26T11:27:33Z

$CERE Wells Fargo analyst Mohit Bansal initiates coverage on Cerevel Therapeutics Hldg with a Overweight rating and announces Price Target of $38.

MarketBeat posted at 2022-09-26T11:23:34Z

Cerevel Therapeutics initiated by Wells Fargo & Company at overweight. https://www.marketbeat.com/r/1822236 $CERE

Holder Stats

1 0
% of Shares Held by All Insider 18.58%
% of Shares Held by Institutions 84.12%
% of Float Held by Institutions 103.32%
Number of Institutions Holding Shares 174

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Fidelity Growth Company Fund 5631647 2022-05-30 147154936 3.8
Federated Hermes Kaufmann Small Cap Fund 2390382 2022-04-29 69990384 1.6099999999999999
Price (T.Rowe) Health Sciences Fund 1773576 2022-03-30 62092895 1.2
Price (T.Rowe) New Horizons Fund 1673965 2022-03-30 58605514 1.13
Fidelity Series Growth Company Fund 1493622 2022-05-30 39028342 1.01
Vanguard Total Stock Market Index Fund 1474921 2022-03-30 51636984 0.9899999999999999
Fidelity Growth Company K6 Fund 1432028 2022-05-30 37418891 0.97
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 1383719 2022-06-29 36585530 0.93
Vanguard Small-Cap Index Fund 1291283 2022-03-30 45207817 0.8699999999999999
Fidelity Select Portfolios - Health Care 1280000 2022-05-30 33446400 0.86

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2022-09-02 Amundi 7,055 $190,000 0.0% 0 0.005%
2022-08-22 Legal & General Group Plc 46,616 $1,230,000 0.0% +34.2% 0.031%
2022-08-18 Goldman Sachs Group Inc. 101,104 $2,670,000 0.0% +22.9% 0.068%
2022-08-17 Advisory Research Inc. 22,824 $600,000 0.1% -47.6% 0.015%
2022-08-16 Woodline Partners LP 255,533 $6,760,000 0.1% -29.4% 0.172%
2022-08-16 Price T Rowe Associates Inc. MD 6,295,908 $166,460,000 0.0% -2.8% 4.240%
2022-08-16 Prudential Financial Inc. 16,569 $440,000 0.0% +14.4% 0.011%
2022-08-16 Public Employees Retirement Association of Colorado 13,713 $360,000 0.0% 0 0.009%
2022-08-15 AQR Capital Management LLC 22,653 $600,000 0.0% +143.8% 0.015%
2022-08-15 State Street Corp 2,414,474 $63,840,000 0.0% +11.7% 1.626%
2022-08-15 Point72 Asset Management L.P. 202,300 $5,350,000 0.0% 0 0.136%
2022-08-15 Sei Investments Co. 11,131 $290,000 0.0% 0 0.007%
2022-08-15 UBS Asset Management Americas Inc. 62,195 $1,640,000 0.0% +83.9% 0.042%
2022-08-13 American International Group Inc. 25,435 $670,000 0.0% +25.8% 0.017%
2022-08-12 Northern Trust Corp 501,877 $13,270,000 0.0% +22.2% 0.338%
2022-08-12 Virtus ETF Advisers LLC 4,259 $110,000 0.0% -18.3% 0.003%
2022-08-12 Credit Suisse AG 48,503 $1,280,000 0.0% +31.5% 0.033%
2022-08-12 Rafferty Asset Management LLC 73,978 $1,960,000 0.0% -34.5% 0.050%
2022-08-12 FMR LLC 22,243,384 $588,120,000 0.1% +0.2% 14.979%
2022-08-12 Rhumbline Advisers 62,367 $1,650,000 0.0% +51.9% 0.042%
2022-08-11 Deutsche Bank AG 32,187 $850,000 0.0% +22.0% 0.022%
2022-08-11 UBS Group AG 52,424 $1,390,000 0.0% +42.1% 0.035%
2022-08-11 Bank of Montreal Can 131,970 $3,700,000 0.0% 0 0.089%
2022-08-11 Alps Advisors Inc. 87,969 $2,330,000 0.0% -42.2% 0.059%
2022-08-11 JPMorgan Chase & Co. 59,113 $1,560,000 0.0% +22.6% 0.040%
2022-08-10 Frazier Life Sciences Management L.P. 202,260 $5,350,000 0.5% +262.2% 0.136%
2022-08-10 Principal Financial Group Inc. 25,309 $670,000 0.0% +4.4% 0.017%
2022-08-09 Swiss National Bank 138,800 $3,670,000 0.0% +33.0% 0.093%
2022-08-05 State Board of Administration of Florida Retirement System 13,710 $360,000 0.0% 0 0.009%
2022-08-04 TD Asset Management Inc. 183,008 $4,840,000 0.0% -6.5% 0.123%
2022-08-03 Nisa Investment Advisors LLC 1,380 $36,000 0.0% +46.8% 0.001%
2022-08-03 Candriam S.C.A. 397,221 $10,500,000 0.1% +57.9% 0.268%
2022-08-03 Handelsbanken Fonder AB 8,700 $230,000 0.0% -15.5% 0.006%
2022-08-01 Victory Capital Management Inc. 19,478 $520,000 0.0% +11.4% 0.013%
2022-07-29 Tekla Capital Management LLC 88,173 $2,330,000 0.1% +19.7% 0.059%
2022-07-29 SG Americas Securities LLC 19,671 $520,000 0.0% 0 0.013%
2022-07-28 Arizona State Retirement System 15,960 $420,000 0.0% +33.7% 0.011%
2022-07-26 Mirae Asset Global Investments Co. Ltd. 15,677 $410,000 0.0% 0 0.011%
2022-06-30 Amalgamated Bank 6,633 $230,000 0.0% -7.0% 0.004%
2022-06-07 Bank of America Corp DE 67,190 $2,350,000 0.0% -12.8% 0.045%
2022-06-02 Verition Fund Management LLC 82,135 $2,880,000 0.0% 0 0.055%
2022-05-20 The Manufacturers Life Insurance Company 109,385 $3,700,000 0.0% +452.8% 0.074%
2022-05-17 Alyeska Investment Group L.P. 105,000 $3,680,000 0.0% 0 0.071%
2022-05-17 Royal Bank of Canada 4,673 $160,000 0.0% -75.4% 0.003%
2022-05-17 Rock Springs Capital Management LP 1,723,341 $60,330,000 1.5% +4.5% 1.164%
2022-05-16 California State Teachers Retirement System 55,347 $1,940,000 0.0% -6.2% 0.037%
2022-05-16 Goldman Sachs Group Inc. 82,265 $2,880,000 0.0% -80.5% 0.056%
2022-05-16 Woodline Partners LP 361,753 $12,670,000 0.2% +52.4% 0.244%
2022-05-16 State Street Corp 2,162,096 $75,700,000 0.0% -2.5% 1.461%
2022-05-16 Frazier Life Sciences Management L.P. 55,835 $1,960,000 0.2% 0 0.038%
2022-05-16 UBS Group AG 36,895 $1,290,000 0.0% -82.5% 0.025%
2022-05-16 Ally Bridge Group NY LLC 170,000 $5,950,000 4.4% 0 0.115%
2022-05-13 Centaurus Financial Inc. 3,000 $110,000 0.0% 0 0.002%
2022-05-13 Renaissance Technologies LLC 9,900 $350,000 0.0% 0 0.007%
2022-05-13 Northern Trust Corp 410,618 $14,380,000 0.0% -3.8% 0.277%
2022-05-13 Verition Fund Management LLC 82,135 $2,880,000 0.0% 0 0.055%
2022-05-13 Charles Schwab Investment Management Inc. 372,561 $13,040,000 0.0% +2.6% 0.252%
2022-05-13 Affinity Asset Advisors LLC 70,000 $2,450,000 0.4% -68.9% 0.047%
2022-05-13 Penserra Capital Management LLC 3,059 $110,000 0.0% -15.9% 0.002%
2022-05-13 First Trust Advisors LP 94,752 $3,320,000 0.0% -11.5% 0.064%
2022-05-13 Prudential Financial Inc. 14,479 $510,000 0.0% 0 0.010%
2022-05-13 American International Group Inc. 20,226 $710,000 0.0% -6.6% 0.014%
2022-05-13 Tekla Capital Management LLC 73,681 $2,580,000 0.1% +79.7% 0.050%
2022-05-13 Candriam Luxembourg S.C.A. 251,618 $8,810,000 0.1% +138.3% 0.170%
2022-05-13 Vanguard Group Inc. 4,809,693 $168,390,000 0.0% +0.2% 3.250%
2022-05-13 Allianz Asset Management GmbH 25,860 $910,000 0.0% +27.6% 0.017%
2022-05-13 Lord Abbett & CO. LLC 729,850 $25,550,000 0.1% +0.1% 0.493%
2022-05-12 BlackRock Inc. 3,391,415 $118,740,000 0.0% -2.7% 2.291%
2022-05-12 Rhumbline Advisers 41,045 $1,440,000 0.0% +11.7% 0.028%
2022-05-12 Metropolitan Life Insurance Co NY 2,803 $98,000 0.0% -76.8% 0.002%
2022-05-12 MetLife Investment Management LLC 25,158 $880,000 0.0% +58.5% 0.017%
2022-05-12 Citigroup Inc. 20,704 $730,000 0.0% -83.0% 0.014%
2022-05-12 HighTower Advisors LLC 76,168 $2,690,000 0.0% +3.6% 0.051%
2022-05-12 Blueshift Asset Management LLC 10,268 $360,000 0.0% 0 0.007%
2022-05-11 Bank of New York Mellon Corp 407,163 $14,250,000 0.0% -7.5% 0.275%
2022-05-11 JPMorgan Chase & Co. 48,206 $1,690,000 0.0% -53.0% 0.033%
2022-05-10 ProShare Advisors LLC 7,642 $270,000 0.0% -14.1% 0.005%
2022-05-10 TD Asset Management Inc. 195,808 $6,860,000 0.0% -9.4% 0.132%
2022-05-09 Swiss National Bank 104,400 $3,660,000 0.0% +9.2% 0.071%
2022-05-09 Teacher Retirement System of Texas 9,159 $320,000 0.0% +9.5% 0.006%
2022-05-05 New York State Common Retirement Fund 30,454 $1,070,000 0.0% +6.8% 0.021%
2022-05-04 Victory Capital Management Inc. 17,484 $510,000 0.0% +121.7% 0.012%
2022-04-29 Nisa Investment Advisors LLC 940 $33,000 0.0% -57.2% 0.001%
2022-04-21 Zurcher Kantonalbank Zurich Cantonalbank 7,134 $250,000 0.0% +30.3% 0.005%
2022-02-19 Woodline Partners LP 237,326 $7,690,000 0.1% +21.5% 0.161%
2022-02-15 Adage Capital Partners GP L.L.C. 310,000 $10,050,000 0.0% +24.0% 0.211%
2022-02-14 Virtus ETF Advisers LLC 5,525 $180,000 0.1% -64.7% 0.004%
2022-02-14 Point72 Hong Kong Ltd 4,702 $150,000 0.0% -44.8% 0.003%
2022-02-14 Affinity Asset Advisors LLC 225,000 $7,300,000 2.6% -13.5% 0.153%
2022-02-11 Allianz Asset Management GmbH 20,260 $660,000 0.0% 0 0.014%
2022-02-10 Candriam Luxembourg S.C.A. 105,599 $3,420,000 0.0% 0 0.072%
2022-02-10 Rafferty Asset Management LLC 135,197 $4,380,000 0.0% +65.1% 0.092%
2022-02-10 Citigroup Inc. 122,049 $3,960,000 0.0% -37.9% 0.083%
2022-02-10 TD Asset Management Inc. 216,108 $7,010,000 0.0% +23.9% 0.147%
2022-02-10 Paradigm Financial Partners LLC 14,490 $410,000 0.0% 0 0.010%
2022-02-10 Teacher Retirement System of Texas 8,364 $270,000 0.0% +22.4% 0.006%
2022-02-10 HighTower Advisors LLC 73,488 $2,370,000 0.0% +2.3% 0.050%
2022-02-09 Principal Financial Group Inc. 24,326 $790,000 0.0% +189.3% 0.017%
2022-02-09 AlphaCrest Capital Management LLC 10,328 $340,000 0.0% 0 0.007%
2022-02-09 Alps Advisors Inc. 170,399 $5,520,000 0.1% -4.0% 0.116%

SEC Filings

Form Type Form Description Filing Date Document Link
4 FORM 4 SUBMISSION 2022-09-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924322031062/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-09-12 https://www.sec.gov/Archives/edgar/data/1805387/000089924322030798/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-08-24 https://www.sec.gov/Archives/edgar/data/1805387/000089924322029606/xslF345X03/doc4.xml
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 2022-08-18 https://www.sec.gov/Archives/edgar/data/1805387/000106299322018390/xslF345X03/form4.xml
SC 13D/A SC 13D/A 2022-08-18 https://www.sec.gov/Archives/edgar/data/1805387/000119312522224144/d393844dsc13da.htm
4 FORM 4 SUBMISSION 2022-08-17 https://www.sec.gov/Archives/edgar/data/1805387/000089924322028978/xslF345X03/doc4.xml
8-K 8-K 2022-08-16 https://www.sec.gov/Archives/edgar/data/1805387/000119312522222349/d392963d8k.htm
8-K 8-K 2022-08-12 https://www.sec.gov/Archives/edgar/data/1805387/000119312522220072/d390163d8k.htm
424B5 424B5 2022-08-12 https://www.sec.gov/Archives/edgar/data/1805387/000119312522220061/d312777d424b5.htm
4 FORM 4 SUBMISSION 2022-08-12 https://www.sec.gov/Archives/edgar/data/1805387/000089924322028481/xslF345X03/doc4.xml
424B5 424B5 2022-08-12 https://www.sec.gov/Archives/edgar/data/1805387/000119312522219191/d312777d424b5.htm
424B5 424B5 2022-08-10 https://www.sec.gov/Archives/edgar/data/1805387/000119312522217368/d312777d424b5.htm
4 FORM 4 SUBMISSION 2022-08-09 https://www.sec.gov/Archives/edgar/data/1805387/000089924322028190/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-08-09 https://www.sec.gov/Archives/edgar/data/1805387/000089924322028185/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-08-09 https://www.sec.gov/Archives/edgar/data/1805387/000089924322028178/xslF345X03/doc4.xml
10-Q 10-Q 2022-08-01 https://www.sec.gov/Archives/edgar/data/1805387/000095017022013665/cere-20220630.htm
8-K 8-K 2022-08-01 https://www.sec.gov/Archives/edgar/data/1805387/000095017022013556/cere-20220801.htm
4 FORM 4 SUBMISSION 2022-07-22 https://www.sec.gov/Archives/edgar/data/1805387/000089924322026577/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-07-07 https://www.sec.gov/Archives/edgar/data/1805387/000089924322025685/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-28 https://www.sec.gov/Archives/edgar/data/1805387/000089924322024387/xslF345X03/doc4.xml
3 FORM 3 SUBMISSION 2022-06-22 https://www.sec.gov/Archives/edgar/data/1805387/000089924322023560/xslF345X02/doc3.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022865/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022864/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022837/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022836/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022834/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022833/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022831/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000089924322022826/xslF345X03/doc4.xml
8-K 8-K 2022-06-15 https://www.sec.gov/Archives/edgar/data/1805387/000119312522174248/d291012d8k.htm
4 FORM 4 SUBMISSION 2022-06-03 https://www.sec.gov/Archives/edgar/data/1805387/000089924322020994/xslF345X03/doc4.xml
EFFECT 2022-05-25 https://www.sec.gov/Archives/edgar/data/1805387/999999999522001591/xslEFFECTX01/primary_doc.xml
UPLOAD 2022-05-20 https://www.sec.gov/Archives/edgar/data/1805387/000000000022005599/filename1.pdf
CORRESP 2022-05-20 https://www.sec.gov/Archives/edgar/data/1805387/000119312522155873/filename1.htm
S-3 S-3 2022-05-10 https://www.sec.gov/Archives/edgar/data/1805387/000119312522145654/d359813ds3.htm
10-Q 10-Q 2022-05-10 https://www.sec.gov/Archives/edgar/data/1805387/000095017022008700/cere-20220331.htm
8-K 8-K 2022-05-10 https://www.sec.gov/Archives/edgar/data/1805387/000095017022008697/cere-20220510.htm
DEFA14A DEFA14A 2022-04-28 https://www.sec.gov/Archives/edgar/data/1805387/000119312522127578/d328017ddefa14a.htm
DEF 14A DEF 14A 2022-04-28 https://www.sec.gov/Archives/edgar/data/1805387/000119312522127554/d328017ddef14a.htm
4 FORM 4 SUBMISSION 2022-04-15 https://www.sec.gov/Archives/edgar/data/1805387/000089924322014882/xslF345X03/doc4.xml
SC 13D/A SC 13D/A 2022-04-07 https://www.sec.gov/Archives/edgar/data/1805387/000007800322000051/sch13da_cere.htm
4 PRIMARY DOCUMENT 2022-04-04 https://www.sec.gov/Archives/edgar/data/1805387/000188312622000001/xslF345X03/primary_doc.xml
4 FORM 4 SUBMISSION 2022-03-31 https://www.sec.gov/Archives/edgar/data/1805387/000089924322012940/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-03-18 https://www.sec.gov/Archives/edgar/data/1805387/000089924322011639/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-03-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322010697/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-03-04 https://www.sec.gov/Archives/edgar/data/1805387/000089924322009392/xslF345X03/doc4.xml
SC 13D/A SC 13D/A 2022-03-03 https://www.sec.gov/Archives/edgar/data/1805387/000119312522064447/d317620dsc13da.htm
S-8 S-8 2022-03-01 https://www.sec.gov/Archives/edgar/data/1805387/000119312522061425/d84838ds8.htm
10-K 10-K 2022-03-01 https://www.sec.gov/Archives/edgar/data/1805387/000095017022002516/cere-20211231.htm
8-K 8-K 2022-03-01 https://www.sec.gov/Archives/edgar/data/1805387/000095017022002409/cere-20220301.htm
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005942/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005941/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005940/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005938/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005934/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005933/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005932/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2022-02-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924322005926/xslF345X03/doc4.xml
SC 13G/A 2022-02-09 https://www.sec.gov/Archives/edgar/data/1805387/000031506622000847/filing.txt
4 FORM 4 SUBMISSION 2022-01-06 https://www.sec.gov/Archives/edgar/data/1805387/000089924322001199/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-28 https://www.sec.gov/Archives/edgar/data/1805387/000089924321049933/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-23 https://www.sec.gov/Archives/edgar/data/1805387/000089924321049620/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-17 https://www.sec.gov/Archives/edgar/data/1805387/000089924321048894/xslF345X03/doc4.xml
EFFECT 2021-11-22 https://www.sec.gov/Archives/edgar/data/1805387/999999999521004446/xslEFFECTX01/primary_doc.xml
CORRESP 2021-11-18 https://www.sec.gov/Archives/edgar/data/1805387/000119312521333808/filename1.htm
UPLOAD 2021-11-18 https://www.sec.gov/Archives/edgar/data/1805387/000000000021013998/filename1.pdf
EFFECT 2021-11-17 https://www.sec.gov/Archives/edgar/data/1805387/999999999521004373/xslEFFECTX01/primary_doc.xml
4 FORM 4 SUBMISSION 2021-11-15 https://www.sec.gov/Archives/edgar/data/1805387/000089924321044579/xslF345X03/doc4.xml
POS AM POS AM 2021-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000119312521325273/d115146dposam.htm
S-3 S-3 2021-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000119312521325266/d230741ds3.htm
424B3 424B3 2021-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000095017021003890/cere-q3-2021-424b3.htm
10-Q 10-Q 2021-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000095017021003885/cere-20210930.htm
8-K 8-K 2021-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000095017021003883/cere-20211110.htm
4 FORM 4 SUBMISSION 2021-09-28 https://www.sec.gov/Archives/edgar/data/1805387/000089924321038068/xslF345X03/doc4.xml
424B3 424B3 2021-09-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521278422/d233355d424b3.htm
8-K 8-K 2021-09-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521278412/d233355d8k.htm
3 2021-09-20 https://www.sec.gov/Archives/edgar/data/1805387/000122520821012490/xslF345X02/doc3.xml
SC 13D/A SC 13D/A CEREVEL THERAPEUTICS HOLDINGS 2021-09-17 https://www.sec.gov/Archives/edgar/data/1805387/000007800321000099/sch13d_axcere.htm
4 FORM 4 SUBMISSION 2021-08-31 https://www.sec.gov/Archives/edgar/data/1805387/000089924321034577/xslF345X03/doc4.xml
25-NSE 2021-08-30 https://www.sec.gov/Archives/edgar/data/1805387/000135445721000991/xslF25X02/primary_doc.xml
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 2021-08-25 https://www.sec.gov/Archives/edgar/data/1805387/000106299321007963/xslF345X03/form4.xml
424B3 424B3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1805387/000156459021043468/cere-424b3.htm
10-Q 10-Q 2021-08-11 https://www.sec.gov/Archives/edgar/data/1805387/000095017021001264/cere-20210630.htm
8-K 8-K 2021-08-11 https://www.sec.gov/Archives/edgar/data/1805387/000095017021001224/cere-20210811.htm
SC 13G 2021-08-10 https://www.sec.gov/Archives/edgar/data/1805387/000031506621001682/filing.txt
424B3 424B3 2021-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000119312521230046/d120918d424b3.htm
8-K 8-K 2021-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000119312521230043/d120918d8k.htm
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 2021-07-09 https://www.sec.gov/Archives/edgar/data/1805387/000106299321006425/xslF345X03/form4.xml
SC 13D/A SC 13D/A 2021-07-09 https://www.sec.gov/Archives/edgar/data/1805387/000119312521211959/d194049dsc13da.htm
SC 13D/A SC 13D/A CEREVEL THERAPEUTICS HOLDINGS 2021-07-09 https://www.sec.gov/Archives/edgar/data/1805387/000007800321000083/cerevel_13dxa1.htm
424B4 424B4 2021-07-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312521207773/d105516d424b4.htm
424B3 424B3 2021-07-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312521206950/d64933d424b3.htm
8-K 8-K 2021-07-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312521206945/d64933d8k.htm
EFFECT 2021-07-01 https://www.sec.gov/Archives/edgar/data/1805387/999999999521002631/xslEFFECTX01/primary_doc.xml
CORRESP 2021-06-29 https://www.sec.gov/Archives/edgar/data/1805387/000119312521203364/filename1.htm
CORRESP 2021-06-29 https://www.sec.gov/Archives/edgar/data/1805387/000119312521203360/filename1.htm
S-1 S-1 2021-06-29 https://www.sec.gov/Archives/edgar/data/1805387/000119312521203293/d105516ds1.htm
424B3 424B3 2021-06-29 https://www.sec.gov/Archives/edgar/data/1805387/000119312521202606/d158663d424b3.htm
8-K 8-K 2021-06-29 https://www.sec.gov/Archives/edgar/data/1805387/000119312521202603/d158663d8k.htm
4 FORM 4 SUBMISSION 2021-06-24 https://www.sec.gov/Archives/edgar/data/1805387/000089924321025758/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-22 https://www.sec.gov/Archives/edgar/data/1805387/000089924321025352/xslF345X03/doc4.xml
424B3 424B3 2021-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000119312521192227/d175359d424b3.htm
8-K 8-K 2021-06-16 https://www.sec.gov/Archives/edgar/data/1805387/000119312521192224/d175359d8k.htm
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023730/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023729/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023723/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023721/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023719/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-14 https://www.sec.gov/Archives/edgar/data/1805387/000089924321023716/xslF345X03/doc4.xml
SC 13G/A 2021-06-10 https://www.sec.gov/Archives/edgar/data/1805387/000162363221000653/form18086.htm
4 FORM 4 SUBMISSION 2021-06-03 https://www.sec.gov/Archives/edgar/data/1805387/000089924321021801/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-06-03 https://www.sec.gov/Archives/edgar/data/1805387/000089924321021786/xslF345X03/doc4.xml
UPLOAD 2021-06-03 https://www.sec.gov/Archives/edgar/data/1805387/000000000021006874/filename1.pdf
3 FORM 3 SUBMISSION 2021-05-28 https://www.sec.gov/Archives/edgar/data/1805387/000089924321021114/xslF345X02/doc3.xml
DRS 2021-05-27 https://www.sec.gov/Archives/edgar/data/1805387/000095012321007371/filename1.htm
424B3 424B3 2021-05-17 https://www.sec.gov/Archives/edgar/data/1805387/000156459021028426/cere-424b3.htm
10-Q 10-Q 2021-05-17 https://www.sec.gov/Archives/edgar/data/1805387/000156459021028420/cere-10q_20210331.htm
8-K 8-K 2021-05-17 https://www.sec.gov/Archives/edgar/data/1805387/000156459021028163/cere-8k_20210517.htm
3 FORM 3 SUBMISSION 2021-05-13 https://www.sec.gov/Archives/edgar/data/1805387/000089924321019433/xslF345X02/doc3.xml
DEFA14A DEFA14A 2021-04-28 https://www.sec.gov/Archives/edgar/data/1805387/000119312521136919/d106215ddefa14a.htm
DEF 14A DEF 14A 2021-04-28 https://www.sec.gov/Archives/edgar/data/1805387/000119312521136895/d106215ddef14a.htm
424B3 424B3 2021-04-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521124700/d161452d424b3.htm
8-K 8-K 2021-04-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521124683/d161452d8k.htm
424B3 424B3 2021-04-13 https://www.sec.gov/Archives/edgar/data/1805387/000119312521113931/d129321d424b3.htm
8-K 8-K 2021-04-13 https://www.sec.gov/Archives/edgar/data/1805387/000119312521113928/d129321d8k.htm
SC 13G/A 2021-04-09 https://www.sec.gov/Archives/edgar/data/1805387/000162363221000449/form17963.htm
424B3 424B3 2021-03-26 https://www.sec.gov/Archives/edgar/data/1805387/000119312521096610/d156390d424b3.htm
EFFECT 2021-03-25 https://www.sec.gov/Archives/edgar/data/1805387/999999999521001125/xslEFFECTX01/primary_doc.xml
POS AM POS AM 2021-03-24 https://www.sec.gov/Archives/edgar/data/1805387/000119312521092770/d156390dposam.htm
10-K 10-K 2021-03-24 https://www.sec.gov/Archives/edgar/data/1805387/000156459021015106/cere-10k_20201231.htm
8-K 8-K 2021-03-24 https://www.sec.gov/Archives/edgar/data/1805387/000119312521091859/d167678d8k.htm
SC 13G 2021-02-12 https://www.sec.gov/Archives/edgar/data/1805387/000162363221000247/cerevel.htm
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005105/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005102/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005101/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005097/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005096/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005095/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-05 https://www.sec.gov/Archives/edgar/data/1805387/000089924321005091/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-03 https://www.sec.gov/Archives/edgar/data/1805387/000089924321004765/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-02-03 https://www.sec.gov/Archives/edgar/data/1805387/000089924321004763/xslF345X03/doc4.xml
3 FORM 3 SUBMISSION 2021-02-01 https://www.sec.gov/Archives/edgar/data/1805387/000089924321003859/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-01 https://www.sec.gov/Archives/edgar/data/1805387/000089924321003858/xslF345X02/doc3.xml
4 FORM 4 SUBMISSION 2021-01-28 https://www.sec.gov/Archives/edgar/data/1805387/000089924321003665/xslF345X03/doc4.xml
424B3 424B3 2021-01-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521012894/d43960d424b3.htm
8-K 8-K 2021-01-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312521012891/d848301d8k.htm
4 FORM 4 SUBMISSION 2021-01-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924321001345/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-01-06 https://www.sec.gov/Archives/edgar/data/1805387/000089924321000688/xslF345X03/doc4.xml
S-8 S-8 2021-01-04 https://www.sec.gov/Archives/edgar/data/1805387/000119312521001022/d81888ds8.htm
3 FORM 3 SUBMISSION 2020-12-11 https://www.sec.gov/Archives/edgar/data/1805387/000089924320033603/xslF345X02/doc3.xml
SC 13G/A 2020-12-10 https://www.sec.gov/Archives/edgar/data/1805387/000008025520001736/cere13ganov20.txt
424B3 424B3 2020-12-09 https://www.sec.gov/Archives/edgar/data/1805387/000119312520313916/d10551d424b3.htm
8-K 8-K 2020-12-09 https://www.sec.gov/Archives/edgar/data/1805387/000119312520313873/d10551d8k.htm
4 FORM 4 SUBMISSION 2020-12-08 https://www.sec.gov/Archives/edgar/data/1805387/000089924320033034/xslF345X03/doc4.xml
EFFECT 2020-12-04 https://www.sec.gov/Archives/edgar/data/1805387/999999999520003413/xslEFFECTX01/primary_doc.xml
424B3 424B3 2020-12-04 https://www.sec.gov/Archives/edgar/data/1805387/000119312520310730/d87562d424b3.htm
CORRESP 2020-12-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312520308377/filename1.htm
UPLOAD 2020-12-01 https://www.sec.gov/Archives/edgar/data/1805387/000000000020011485/filename1.pdf
S-1 S-1 2020-11-25 https://www.sec.gov/Archives/edgar/data/1805387/000119312520303638/d87562ds1.htm
8-K 8-K 2020-11-20 https://www.sec.gov/Archives/edgar/data/1805387/000119312520299442/d97592d8k.htm
8-K/A 8-K/A 2020-11-16 https://www.sec.gov/Archives/edgar/data/1805387/000119312520294894/d63191d8ka.htm
10-Q 10-Q 2020-11-16 https://www.sec.gov/Archives/edgar/data/1805387/000114036120025695/brhc10016853_10q.htm
8-K 8-K 2020-11-16 https://www.sec.gov/Archives/edgar/data/1805387/000119312520293723/d34244d8k.htm
4 FORM 4 SUBMISSION 2020-11-12 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030861/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-11-12 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030860/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-11-12 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030857/xslF345X03/doc4.xml
SC 13G 2020-11-10 https://www.sec.gov/Archives/edgar/data/1805387/000008025520001708/cere13goct20.txt
SC 13D SC 13D CEREVEL THERAPEUTICS HOLDINGS, INC. 2020-11-06 https://www.sec.gov/Archives/edgar/data/1805387/000007800320000074/cerevel_13dxv3.htm
SC 13D SC 13D 2020-11-04 https://www.sec.gov/Archives/edgar/data/1805387/000119312520285634/d98493dsc13d.htm
3 FORM 3 SUBMISSION 2020-11-02 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030141/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-11-02 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030140/xslF345X02/doc3.xml
8-K 8-K 2020-11-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312520283964/d33687d8k.htm
4 FORM 4 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030033/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030032/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030028/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030026/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030025/xslF345X03/doc4.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030022/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030020/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030018/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030017/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030015/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030014/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030011/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030010/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030007/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030004/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030003/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-30 https://www.sec.gov/Archives/edgar/data/1805387/000089924320030002/xslF345X02/doc3.xml
4 FORM 4 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029743/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029742/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029740/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029741/xslF345X03/doc4.xml
3 FORM 3 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029733/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029732/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029731/xslF345X02/doc3.xml
4 PRIMARY DOCUMENT 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000007800320000067/xslF345X03/primary_doc.xml
3 PRIMARY DOCUMENT 2020-10-29 https://www.sec.gov/Archives/edgar/data/1805387/000007800320000066/xslF345X02/primary_doc.xml
25-NSE 2020-10-27 https://www.sec.gov/Archives/edgar/data/1805387/000135445720000643/xslF25X02/primary_doc.xml
425 425 2020-10-26 https://www.sec.gov/Archives/edgar/data/1805387/000119312520277065/d893774d425.htm
8-K 8-K 2020-10-26 https://www.sec.gov/Archives/edgar/data/1805387/000119312520277060/d893774d8k.htm
4 FORM 4 SUBMISSION 2020-10-22 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029111/xslF345X03/doc4.xml
3 FORM 3 SUBMISSION 2020-10-22 https://www.sec.gov/Archives/edgar/data/1805387/000089924320029108/xslF345X02/doc3.xml
8-K 8-K 2020-10-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312520273498/d249417d8k.htm
425 8-K 2020-10-21 https://www.sec.gov/Archives/edgar/data/1805387/000119312520273499/d249417d8k.htm
EFFECT 2020-10-07 https://www.sec.gov/Archives/edgar/data/1805387/999999999520002770/xslEFFECTX01/primary_doc.xml
424B3 424B3 2020-10-07 https://www.sec.gov/Archives/edgar/data/1805387/000119312520265596/d43082d424b3.htm
8-K 8-K 2020-10-05 https://www.sec.gov/Archives/edgar/data/1805387/000119312520263959/d48823d8k.htm
425 8-K 2020-10-05 https://www.sec.gov/Archives/edgar/data/1805387/000119312520263960/d48823d8k.htm
CORRESP 2020-10-05 https://www.sec.gov/Archives/edgar/data/1805387/000119312520263890/filename1.htm
S-4/A S-4/A 2020-10-02 https://www.sec.gov/Archives/edgar/data/1805387/000119312520262639/d43082ds4a.htm
CORRESP 2020-09-17 https://www.sec.gov/Archives/edgar/data/1805387/000119312520248128/filename1.htm
S-4/A S-4/A 2020-09-17 https://www.sec.gov/Archives/edgar/data/1805387/000119312520248121/d43082ds4a.htm
UPLOAD 2020-09-04 https://www.sec.gov/Archives/edgar/data/1805387/000000000020008357/filename1.pdf
10-Q 10-Q 2020-08-14 https://www.sec.gov/Archives/edgar/data/1805387/000114036120018489/brhc10013955_10q.htm
S-4 S-4 2020-08-07 https://www.sec.gov/Archives/edgar/data/1805387/000119312520212601/d43082ds4.htm
425 425 2020-07-31 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017185/nc10013869_8k.htm
8-K 8-K 2020-07-31 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017184/nc10013869_8k.htm
425 425 2020-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017078/nc10013869.htm
8-K 8-K 2020-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017077/nc10013869.htm
8-K FORM 8-K 2020-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017009/nc10013869x1_8k.htm
425 FORM 8-K 2020-07-30 https://www.sec.gov/Archives/edgar/data/1805387/000114036120017010/nc10013869x1_8k.htm
8-K FORM 8-K 2020-07-22 https://www.sec.gov/Archives/edgar/data/1805387/000114036120016538/nc10013644x1_8k.htm
8-K FORM 8-K 2020-06-15 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013787/nc10012774x1_8k.htm
4 FORM 4 2020-06-09 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013462/xslF345X03/form4.xml
4 FORM 4 2020-06-09 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013461/xslF345X03/form4.xml
4 FORM 4 2020-06-09 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013458/xslF345X03/form4.xml
8-K FORM 8K 2020-06-09 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013438/nt10009663x11_8k.htm
424B4 424B4 2020-06-08 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013322/nt10009663x10_424b4.htm
CERT 2020-06-05 https://www.sec.gov/Archives/edgar/data/1805387/000135445720000223/8A_Cert_ARYB-.pdf
EFFECT 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/999999999520001338/xslEFFECTX01/primary_doc.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013101/xslF345X02/form3.xml
S-1MEF S-1MEF 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013097/nt10009663x9_s1mef.htm
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013098/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013095/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013094/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013092/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013091/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013090/xslF345X02/form3.xml
3 FORM 3 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013089/xslF345X02/form3.xml
8-A12B 8-A12B 2020-06-04 https://www.sec.gov/Archives/edgar/data/1805387/000114036120013039/form8a12b.htm
CORRESP 2020-06-02 https://www.sec.gov/Archives/edgar/data/1805387/000114036120012915/filename1.htm
CORRESP 2020-06-02 https://www.sec.gov/Archives/edgar/data/1805387/000114036120012912/filename1.htm
CORRESP 2020-06-02 https://www.sec.gov/Archives/edgar/data/1805387/000114036120012910/filename1.htm
S-1/A S-1/A 2020-05-29 https://www.sec.gov/Archives/edgar/data/1805387/000114036120012732/nt10009663x4_s1a.htm
S-1 S-1 2020-05-19 https://www.sec.gov/Archives/edgar/data/1805387/000114036120011893/nt10009663x3_s1.htm
DRS/A 2020-04-17 https://www.sec.gov/Archives/edgar/data/1805387/000114036120009125/filename1.htm
DRS 2020-03-10 https://www.sec.gov/Archives/edgar/data/1805387/000114036120005201/filename1.htm